Short answer
Hologic (HOLX) filed its Q2 2025 10-Q quarterly report on Jul 31, 2025 for the quarter ended Jun 28, 2025. Quarterly revenue was $1.0B (up 1.2% year over year) with net income of $195M.
Q2 2025 key financials · XBRL
- Revenue
- $1.0B
- +1.2% YoY · +1.8% QoQ
- Net income
- $195M
- +0.2% YoY · +1220.1% QoQ
- Operating margin
- 24.9%
- Gross margin
- 56.3%
- EPS (diluted)
- $0.86
- +3.6% YoY · +1328.6% QoQ
Source: XBRL data from the Hologic (HOLX) Q2 2025 10-Q on SEC EDGAR. USD.
Hologic Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors disclosed this quarter
- Most materially updated risk: potential material impacts from inaccurate estimates in revenue recognition, asset valuation, and goodwill impairments due to changing assumptions
- Compliance risk: contingent liabilities and tax reserves subject to changes impacting financial condition materially
- Operational risk: inventory reserves for excess/obsolete stocks critical due to shifting demand and supply chain uncertainties
- Financial risk: reliance on estimates affecting valuation of deferred tax assets and related allowance, impacting reported liquidity and financial results
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Hologic quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.